Wockhardt gets tentative USFDA nod for anti-depression drug

Pharma and bio-technology company Wockhardt has received tentative approval from the US Food and Drugs Administration (FDA) for marketing 20mg, 30mg and 60mg delayed release capsules of Duloxetine Hydrochloride, a drug used for treating depression.

July 08, 2011 / 15:00 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Moneycontrol Bureau

Pharma and bio-technology company Wockhardt has received tentative approval from the US Food and Drugs Administration (FDA) for marketing 20mg, 30mg and 60mg delayed release capsules of Duloxetine Hydrochloride, a drug used for treating depression.

Wockhardt

first published: Jul 8, 2011 10:40 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.